USPTO serial 79335517
SEFIRA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 31, 2023
- Examiner
- RIEPEL, CHRISTINA MAXINE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEFIRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yue (Robert) Xu
Yue (Robert) Xu Apex Attorneys at Law, LLP160 Alamo Plaza #942Alamo, CA 94507UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, namely, antibiotics; diagnostic preparations for medical and veterinary use; sanitary preparations for medical purposes; dietetic food and preparations adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; plasters, namely, materials for medical dressings; disinfectants; adjuvants for medical purposes; cooling sprays for medical purposes; albumin dietary supplements; alginate dietary supplements; amino acids for medical purposes; amino acid preparations for medical purposes; analgesics; anaesthetics; vermifuges; anti-uric preparations; antibacterial pharmaceuticals; antiseptics; autonomic drugs for medical purposes in treating diseases or disorders related to the parasympathetic nervous system; germicides; balms for medical purposes; balsamic preparations for medical purposes; albuminous preparations being dietetic foods for medical purposes; albuminous foodstuffs for medical purposes; activated charcoal dietary supplements; biological preparations for medical purposes for the treatment of cancer; bronchodilating preparations; vaccines; vitamin preparations; vitamin and mineral preparations for medical use; lead water, namely, dietetic beverages for treating heavy metal poisoning; mineral waters for medical purposes; dietary fibre for use as a dietary supplement; herbal remedies, namely, herbal extracts for medical purposes; homogenized food adapted for medical purposes; disinfectants for hygiene purposes; diagnostic preparations for medical purposes; dietary supplements; nutritional and dietary supplements for stress relief; antioxidants being dietary supplements; anti-cancer preparations; nutritional and dietary supplements for strengthening the immune system; dietary supplements intended to supplement a normal diet or to have health benefits; dietary supplements consisting of vitamins; royal jelly dietary supplements; glucose dietary supplements; pollen dietary supplements; dietary supplements with a cosmetic effect; linseed dietary supplements; linseed oil dietary supplements; acai powder dietary supplements; propolis dietary supplements; wheat germ dietary supplements; natural dietary supplements for treatment of claustrophobia; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; dietetic foods adapted for medical purposes; yeast dietary supplements; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; elixirs being pharmaceutical preparations for treatment of headache; enzyme dietary supplements; febrifuges; carbohydrate-based dietary supplements; blood substitutes for medical or veterinary purposes; nervines being medicines for treatment of nerve disorders; drugs for medical purposes in the treatment of nervous system disorders; recombinant drug-metabolizing enzyme being biochemical preparations for veterinary purposes; immunostimulants; casein dietary supplements; amino acids for pharmaceutical purposes; medicinal roots; depuratives for the body; lecithin dietary supplements; medicines for human purposes in the treatment of nervous system disorders; medicated candy; lotions for pharmaceutical purposes in the treatment of dermatological conditions; magnesia for pharmaceutical purposes as an antacid and dietary supplement; medicated soap; mineral food supplements; vitamins; vitamin supplement patches; medicinal drinks; medicinal infusions for treating gastrointestinal disorders; herbal tinctures for medical purposes; nutraceutical preparations for therapeutic or medical purposes as a dietary supplement; fumigating sticks; fumigation preparations for medical purposes; medicinal oils; mouthwashes for medical purposes; headache relief sticks; antioxidant food supplement pills; by-products of the processing of cereals for medical purposes including as dietetic preparations adapted for medical use; nutritional supplements; preparations in the nature of sexual stimulants for increasing sexual prowess; human immune globulin for use in autoimmune medical treatments; therapeutic drugs and agents for weight control and appetite suppression; pre-filled syringes for medical purposes sold filled with insulin; bath preparations for medical purposes; dietary supplements for animals; pharmaceutical preparations for the treatment and prevention of influenza; opotherapy preparations; preparations of trace elements in the nature of dietary and nutritional supplements for human and animal use; medicated toiletry preparations; freezedried food adapted for medical purposes; protein dietary supplements; soy protein dietary supplements; antivirals; antiarrhythmic drugs; anti-inflammatories; antiepileptic drugs; antitumor drugs; sedatives; tissues impregnated with pharmaceutical skin lotions; syrups for pharmaceutical purposes for treatment of cough and cold; medicated salts for mineral water baths; mineral water salts for medical purposes; vegan protein for use as a nutritional supplement in ready-to-drink beverages; cough pastilles for pharmaceutical purposes; therapeutic preparations for the bath; thermal water, namely, vitamin and mineral enriched water for medical purposes; tonics, namely, medicines for use in the treatment of cardiovascular diseases; medicinal herbs; pharmaceuticals, namely, antihelmintics, psychotropics; pharmaceutical substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, and cognitive disorders; ferments for pharmaceutical purposes; diarrhoea medication; phytotherapy preparations for medical purposes; dietary food supplements for medical purposes; medicated sweets; medicinal tea; asthmatic tea; herbal teas for medicinal purposes; medicated shampoos; medicated dry shampoo | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 1, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 1, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 31, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 31, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 31, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 3, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 16, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 16, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 15, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 15, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 14, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 26, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 26, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 26, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 13, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 13, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 13, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 13, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 13, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 16, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 9, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 16, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 16, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 13, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 12, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 15, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 11, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 10, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |